IL-33 at the Crossroads of Metabolic Disorders and Immunity
As a cytokine in interleukin-1(IL-1) family, interleukin-33(IL-33) usually exists in the cytoplasm and cell nucleus. When the cells are activated or damaged, IL-33 can be secreted into extracellular and regulate the functions of various immune cells through binding to its specific receptor suppressi...
Main Authors: | Lei Tu, Lijing Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-01-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2019.00026/full |
Similar Items
-
The IL-33/ST2 Axis in Immune Responses Against Parasitic Disease: Potential Therapeutic Applications
by: Nathan Ryan, et al.
Published: (2020-04-01) -
IL-33 Alarmin and Its Active Proinflammatory Fragments Are Released in Small Intestine in Celiac Disease
by: Federico Perez, et al.
Published: (2020-10-01) -
IL33 and Mast Cells—The Key Regulators of Immune Responses in Gastrointestinal Cancers?
by: Moritz F. Eissmann, et al.
Published: (2020-07-01) -
Hyperactivity of Innate Immunity Triggers Pain via TLR2-IL-33-Mediated Neuroimmune Crosstalk
by: Junting Huang, et al.
Published: (2020-10-01) -
Interleukin 33 Selectively Augments Rhinovirus-Induced Type 2 Immune Responses in Asthmatic but not Healthy People
by: Lisa M. Jurak, et al.
Published: (2018-08-01)